EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS‐CoV‐2 nucleocapsid protein and its liquid–liquid phase separation

Ahmed Eltayeb iD, Faisal Al-Sarraj iD, Mona Alharbi, Raed Albiheyri iD, Ehab H Mattar, Isam M Abu Zeid, Thamer A Bouback, Atif Bamagoos, Vladimir N Uversky iD, Alberto Rubio-Casillas, Elrashdy M Redwan iD

Journal of Cellular Biochemistry · 2024

DOI: 10.1002/jcb.30530 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular Biochemistry, 2024. Verfasst von Ahmed Eltayeb und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 272 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When the SARS‐CoV‐2 virus infects humans, it leads to a condition called COVID‐19 that has a wide spectrum of clinical manifestations, from no symptoms to acute respiratory distress syndrome. The virus initiates damage by attaching to the ACE‐2 protein on the surface of endothelial cells that line the blood vessels and using these cells as hosts for replication. Reactive oxygen species levels are increased during viral replication, which leads to oxidative stress. About three‐fifths (~60%) of the people who get infected with the virus eradicate it from their body after 28 days and recover their normal activity. However, a large fraction (~40%) of the people who are infected with the virus suffer from various symptoms (anosmia and/or ageusia, fatigue, cough, myalgia, cognitive impairment, insomnia, dyspnea, and tachycardia) beyond 12 weeks and are diagnosed with a syndrome called long COVID. Long‐term clinical studies in a group of people who contracted SARS‐CoV‐2 have been contrasted with a noninfected matched group of people. A subset of infected people can be distinguished by a set of cytokine markers to have persistent, low‐grade inflammation and often self‐report two or more bothersome symptoms. No medication can alleviate their symptoms efficiently. Coronavirus nucleocapsid proteins have been investigated extensively as potential drug targets due to their key roles in virus replication, among which is their ability to bind their respective genomic RNAs for incorporation into emerging virions. This review highlights basic studies of the nucleocapsid protein and its ability to undergo liquid–liquid phase separation. We hypothesize that this ability of the nucleocapsid protein for phase separation may contribute to long COVID. This hypothesis unlocks new investigation angles and could potentially open novel avenues for a better understanding of long COVID and treating this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Post-Acute COVID-19 SyndromeCoronavirus Nucleocapsid ProteinsEndothelial CellsPhase SeparationNucleocapsid Proteins

Stichwörter der Autor:innen

SARS-CoV-2liquid-liquid phase separationlong COVIDnucleocapsid protein

Substanzen

Coronavirus Nucleocapsid ProteinsNucleocapsid Proteins

Autor:innen und Institutionen

  • Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Centre of Excellence in Bionanoscience Research, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Immunology Unit, King Fahad Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Moscow Region, Russia.
  • Autlan Regional Hospital, Health Secretariat, Autlan, Jalisco, Mexico.

ORCID-Profile: Ahmed Eltayeb, Faisal Al-Sarraj, Raed Albiheyri, Vladimir N Uversky, Elrashdy M Redwan

Zitieren

APA

Eltayeb, A., Al-Sarraj, F., Alharbi, M., Albiheyri, R., Mattar, E. H., Abu Zeid, I. M., Bouback, T. A., Bamagoos, A., Uversky, V. N., Rubio-Casillas, A., & Redwan, E. M. (2024). Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS‐CoV‐2 nucleocapsid protein and its liquid–liquid phase separation. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30530

Vancouver

Eltayeb A, Al-Sarraj F, Alharbi M, Albiheyri R, Mattar EH, Abu Zeid IM, et al. Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS‐CoV‐2 nucleocapsid protein and its liquid–liquid phase separation. Journal of Cellular Biochemistry. 2024. doi:10.1002/jcb.30530

BibTeX
@article{Eltayeb2024,
  author = {Eltayeb, Ahmed and Al-Sarraj, Faisal and Alharbi, Mona and Albiheyri, Raed and Mattar, Ehab H and Abu Zeid, Isam M and Bouback, Thamer A and Bamagoos, Atif and Uversky, Vladimir N and Rubio-Casillas, Alberto and Redwan, Elrashdy M},
  title = {Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS‐CoV‐2 nucleocapsid protein and its liquid–liquid phase separation},
  journal = {Journal of Cellular Biochemistry},
  year = {2024},
  doi = {10.1002/jcb.30530}
}
Kostenlos starten →